24/7
Buzz
Startups
VC
AI
DefenseTech
Opinions
Events
ScaleUp House
Promising Startups 2026
2026 VC Survey
Boarding Pass
CTalk
BiblioTech
Appointments
Tech Gateways
HR - The Next Leap
Ctech Testimonials
Projects
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Epitomee
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
DefenseTech
OPINIONS
ScaleUp House
EVENTS
Projects
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
14:22
Galaxy S26 FE review: A cheaper Samsung flagship, with compromises
12:44
Maccabi Haifa owner seeks $100 million sale of the club
12:22
Israel is heading into an election without a serious debate about its economy
11:57
Israel’s natural water reserves hit 100-year low after two years of drought
More stories
Buzz
Most popular
Daily
Weekly
1
One-year-old Israeli AI startup with six employees acquired for estimated $100 million
2
CrowdStrike in advanced talks to acquire Israeli startup Orion for $500 million
3
Lionel Messi is building a business empire that will outlast his football career
4
Intel’s Lip-Bu Tan says AI companies will have to prove the returns justify the spending
5
Microsoft Israel cuts hit AI agent team, with 50 Copilot Studio employees summoned to pre-dismissal hearings
More news
Epitomee
4 stories about Epitomee
Epitomee surges 200% in two days on FDA approval for weight loss pill
16.09.24
|
Adiel Eithan Mustaki
Investors are hopeful, but the company must now face an uphill battle in a crowded market.
Weight loss pill maker Epitomee’s stock sinks 70% after Nestlé cancels agreement
04.12.23
|
Adiel Eithan Mustaki
The Swiss conglomerate notified Epitomee that it has decided not to market its product as the clinical trial results measuring the disparity in the weight loss rate between patients who took the pill and the control group did not reach the previously agreed upon success level
Weight loss pill success sparks stock surge at Epitomee Medical
04.09.23
|
Adiel Eithan Mustaki
The company, which has not yet published the full results of its study, plans to seek FDA approval via the 510(k) pathway
Weight-Loss Pill Developer Epitomee Raises $8 Million
10.04.19
|
CTech
Epitomee develops an orally administered capsule that affects the stomach through mechanosensory stimulation, encouraging prolonged gastric emptying and giving patients the sensation of being full